Target intelligence / Profile preview

Helicobacter pylori surface and thiol-containing enzymes

Molecular classification
Enzyme, Bacterial surface protein, Oxidoreductase, Hydrolase
01

Overview

Helicobacter pylori surface and thiol-containing enzymes represent a collective group of bacterial proteins essential for the survival, colonization, and pathogenesis of H. pylori in the human stomach. This group includes the critical enzyme urease, which neutralizes gastric acid via urea hydrolysis, and various redox-active enzymes like thioredoxin reductase (TrxR) and alkyl hydroperoxide reductase (AhpC) that protect the pathogen from oxidative stress (Tsang et al., 2011; Wang et al., 2015). These enzymes are primary targets for bismuth-containing therapeutic agents, such as bismuth subsalicylate and colloidal bismuth subcitrate, which exert antimicrobial effects by binding to functional thiol (sulfhydryl) groups (Ge & Sun, 2007). This binding leads to the irreversible inactivation of the enzymes and disrupts bacterial metabolism and cell wall integrity (Cun & Sun, 2010). Targeting these proteins is a cornerstone of multi-drug regimens used to treat peptic ulcers and prevent gastric cancer. The multi-target nature of these interactions helps reduce the likelihood of the bacterium developing resistance compared to single-target antibiotics (Ge & Sun, 2007).

Other names
H. pylori thiol-dependent enzymesBismuth-binding proteins in H. pyloriH. pylori sulfhydryl-containing enzymes
02

Mechanism of action

Bismuth compounds bind with high affinity to the thiol groups of these enzymes, leading to irreversible inhibition of their catalytic activity and disruption of bacterial cell wall integrity and adherence (Ge & Sun, 2007; Tsang et al., 2011).

03

Biological functions

Acid neutralizationRedox homeostasisBacterial colonizationPathogenesisMetabolic regulation
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Bismuth-induced neurotoxicity (rare)Bismuth-induced stool darkeningPotential for systemic bismuth accumulation with prolonged useRisk of salicylate toxicity with bismuth subsalicylate
06

Interacting drugs

Bismuth subsalicylate

3 more in the full profile.

07

Biomarkers

Urea breath testH. pylori stool antigenRapid urease test (CLOtest)Serological H. pylori antibody test

Beyond the preview

Go deeper on Helicobacter pylori surface and thiol-containing enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori surface and thiol-containing enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call